Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.76 |
| ▸ | THRB | P10828 | 1/20 | 0.76 |
| ▸ | HTT | P42858 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | LPAR3 | Q9UBY5 | 11/20 | 0.55 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.55 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.55 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL3650059 | 1.00 | MEN1 (0.76) | MEN1THRBHTTKMT2AMAPT | |
| Phosphoric Acid SCHEMBL28063201 | 1.00 | MEN1 (0.76) | MEN1THRBHTTKMT2AMAPT | |
| Phosphoric Acid SCHEMBL11152061 | 1.00 | MEN1 (0.76) | MEN1THRBHTTKMT2AMAPT | |
| Phosphoric Acid SCHEMBL28989888 | 0.98 | MEN1 (0.73) | MEN1THRBHTTKMT2AMAPT | |
| Phosphoric Acid SCHEMBL20913262 | 0.98 | MEN1 (0.73) | MEN1THRBHTTKMT2AMAPT | |
| Phosphoric Acid SCHEMBL28379483 | 0.98 | MEN1 (0.80) | MEN1THRBHTTKMT2AMAPT | |
| Phosphoric Acid SCHEMBL29281392 | 0.94 | MEN1 (0.65) | MEN1THRBHTTKMT2AMAPT | |
| Phosphoric Acid SCHEMBL28379356 | 0.92 | MEN1 (0.63) | MEN1THRBHTTKMT2AMAPT | |
| Phosphoric Acid SCHEMBL10929308 | 0.92 | MEN1 (0.63) | MEN1THRBHTTKMT2AMAPT | |
| Butoxyethanol SCHEMBL31493913 | 0.91 | TSHR (0.77) | MEN1THRBHTTKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617959-B2 | Peelable ink composition for non-porous substrates | SOCIéTé BIC (FR) | 2026-05-05 | — | — | US | claimed |
| EP-4127083-B1 | PEELABLE INK COMPOSITION FOR NON-POROUS SUBSTRATES | SOCIéTé BIC (FR) | 2025-12-17 | — | — | EP | claimed |
| US-11696877-B2 | Gel network hair treatment compositions with reduced odor | WELLA OPERATIONS US, LLC (US) | 2023-07-11 | — | — | US | claimed |
| US-20230105735-A1 | PEELABLE INK COMPOSITION FOR NON-POROUS SUBSTRATES | SOCIéTé BIC (FR) | 2023-04-06 | — | — | US | claimed |
| US-11589581-B2 | Disinfectant formulation | LABORATOIRE M2 (CA) | 2023-02-28 | — | — | US | claimed |
| EP-3290086-B1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOUR | WELLA OPERATIONS US LLC (US) | 2022-07-27 | — | — | EP | claimed |
| US-20260144741-A1 | NOVEL COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2026-05-28 | — | — | US | disclosed |
| EP-4748367-A2 | SUNSCREEN COMPOSITION | DSM IP Assets B.V. (NL) | 2026-05-27 | — | — | EP | disclosed |
| US-12636242-B2 | Increased solubilization of diethylamino hydroxybenzoyl hexyl benzoate | DSM IP ASSETS B.V. (NL) | 2026-05-26 | — | — | US | disclosed |
| US-12636243-B2 | Increased solubilization of Iscotrizinol | DSM IP ASSETS B.V. (NL) | 2026-05-26 | — | — | US | disclosed |
| US-12629325-B2 | Increased solubilization of Bemotrizinol | DSM IP ASSETS B.V. (NL) | 2026-05-19 | — | — | US | disclosed |
| US-12629327-B2 | Keratin-based hair straightening formulations, methods and systems | BEAUTY BIOLABS LLC (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4568640-B1 | SUNSCREEN COMPOSITION | DSM IP ASSETS BV (NL) | 2026-05-13 | — | — | EP | disclosed |
| CN-1206395-C | Dispersant slurries for making elastic fiber | DU PONT (US) | 2005-06-15 | — | — | CN | disclosed |
| US-6716523-B2 | SPANDEX PREPARED WITH DISPERSANT SLURRY CONSISTING OF INORGANIC PARTICULATE, PHOSPHATED BLOCK POLYETHERSILOXANE ALCOHOL OR AROMATIC- OR ALKYLAROMATIC-TERMINATED PHOSPHATED POLYETHER ALCOHOL AS DISPERSANT SOLUBLE IN SELECTED LIQUID | E. I. DU PONT DE NEMOURS AND CO. | 2004-04-06 | — | — | US | disclosed |
| US-6531514-B2 | Phosphated block poly(alkylsiloxane)-poly(alkyleneether) alcohol or aromatic- or alkylaromatic-terminated phosphated poly(alkyleneether) alcohol dispersants | E.I. DU PONT DE NEMOURS AND COMPANY | 2003-03-11 | — | — | US | disclosed |
| EP-1264015-A1 | DISPERSANT SLURRIES FOR MAKING SPANDEX | E. I. du Pont de Nemours and Company (US) | 2002-12-11 | — | — | EP | disclosed |
| WO-2001068959-A1 | DISPERSANT SLURRIES FOR MAKING SPANDEX$m(3) | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-09-20 | — | — | WO | disclosed |
| US-4370404-A | Desensitizing solution for lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1983-01-25 | — | — | US | disclosed |
| US-4328304-A | HYDROPHICIC COLLOID, POLYMERIZATION INHIBITOR | FUJI PHOTO FILM CO., LTD. (JP) | 1982-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629327-B2 | Keratin-based hair straightening formulations, methods and systems | KRT18, HCN4, COL14A1 | MEN1 1184/4885THRB 2160/4885HTT 3275/4885 |
| US-12629325-B2 | Increased solubilization of Bemotrizinol | CUTA, CYP51A1, SCD | MEN1 3115/4885THRB 4753/4885HTT 3409/4885 |
| US-12617959-B2 | Peelable ink composition for non-porous substrates | FLNB, NUCB2, DYRK1B | MEN1 3644/4885THRB 2257/4885HTT 2251/4885 |
| US-12636242-B2 | Increased solubilization of diethylamino hydroxybenzoyl hexyl benzoate | SCD, CUTA, TRPA1 | MEN1 4365/4885THRB 3586/4885HTT 1520/4885 |
| US-12636243-B2 | Increased solubilization of Iscotrizinol | CUTA, SCD, SCD5 | MEN1 4498/4885THRB 3973/4885HTT 3676/4885 |
| US-20260144741-A1 | NOVEL COMPOSITIONS | BRCA1, DSG1, MUC1 | MEN1 3650/4885THRB 4082/4885HTT 3381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.